Aflac (AFL, Life insurers) Stock Valuation & Fair Value Trading above its usual valuation
Aflac (AFL, Life insurers) trades at a current P/E of 16.1, about 37% above its historical normal valuation, with a forward growth estimate of 5.1% and a PEG of 3.17. Analysts' one-year estimates have been hit 55% of the time. Priced at its historical normal P/E of 11.8 on the same blended earnings, the 2026-10-09 close of $114.54 corresponds to about $83.90 a share. This is a valuation reference, not a price target.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.
- Price $115.89 at the 2026-10-12 close, 1.4% above the 20-day average ($114.29) and 1.0% below the 50-day ($117.02).
- RSI (14) at 54.2.
- 52-week range $103.54 to $128.90: the price is 10.1% below the high and 11.9% above the low.
The Street vs SeerForecast
Wall Street's mean price target for AFL is $117.80 across 15 analysts, 1.6% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: trading above its usual valuation. When the two disagree, start your digging there.
Valuation flags
- Overvalued by 37%
Verdict history
tickerseer's rating has been trading above its usual valuation since 2026-06-10.
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 38 weeks
Frequently asked questions
Is Aflac stock overvalued?
At a current P/E of 16.1 versus its historical normal P/E of 11.8, Aflac trades about 37% above its typical valuation, with a PEG of 3.17 on 5.1% forward growth. tickerseer currently rates it trading above its usual valuation.
What is Aflac's fair value and PEG?
Aflac trades at a current P/E of 16.1 against a historical normal P/E of 11.8, a PEG of 3.17, and a forward growth estimate of 5.1%. Priced at its historical normal P/E of 11.8 on the same blended earnings, the 2026-10-09 close of $114.54 corresponds to about $83.90 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Aflac changed?
tickerseer's rating has been trading above its usual valuation since 2026-06-10.
What is the analyst price target for Aflac?
The mean Wall Street price target for Aflac is $117.80 across 15 analysts, 1.6% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Life insurers. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.